RUNX2 and glioblastoma: RUNX2 was detrimental in UVM, KICH, ACC, LGG, KIRC, BLCA, PAAD, MESO, GBM, and SARC (HR>1, p<0.05) but protective in SKCM (HR<1, p<0.05).